Doi.org/10.1002/cncr.10307

Target Article

High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study  ; Thomas M Behr Frank Griesinger Joachim Riggert Stefan Gratz Martin Béhé Cornelia C Kaufmann Be; NULL; 02/12/2002; https://doi.org/10.1002/cncr.10307

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.